99 related articles for article (PubMed ID: 29945702)
1. [Expression and Clinical Significance of LC-3 and P62
in Non-small Cell Lung Cancer].
Wang C; Li Y; Li Y; Gong H; Zhang H; Yuan Y; Li W; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):445-450. PubMed ID: 29945702
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
Schläfli AM; Adams O; Galván JA; Gugger M; Savic S; Bubendorf L; Schmid RA; Becker KF; Tschan MP; Langer R; Berezowska S
Oncotarget; 2016 Jun; 7(26):39544-39555. PubMed ID: 27250032
[TBL] [Abstract][Full Text] [Related]
3. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
Wang X; Du Z; Li L; Shi M; Yu Y
Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774
[TBL] [Abstract][Full Text] [Related]
4. [The expressions of STAT3, WWOX and c-myc in human non small cell lung cancer tissue and correlativity analysis].
Hu FY; Wang LP; Hou LL; Yin G; Wang HC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1203-5, 1209. PubMed ID: 21138684
[TBL] [Abstract][Full Text] [Related]
5. Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.
Wang BS; Liu YZ; Yang Y; Zhang Y; Hao JJ; Yang H; Wang XM; Zhang ZQ; Zhan QM; Wang MR
Clin Sci (Lond); 2013 Feb; 124(3):203-14. PubMed ID: 22963397
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma.
Inoue D; Suzuki T; Mitsuishi Y; Miki Y; Suzuki S; Sugawara S; Watanabe M; Sakurada A; Endo C; Uruno A; Sasano H; Nakagawa T; Satoh K; Tanaka N; Kubo H; Motohashi H; Yamamoto M
Cancer Sci; 2012 Apr; 103(4):760-6. PubMed ID: 22320446
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of APC and c-Myc and its implication on non-small cell lung cancer].
Wang SF; Liu Q; Zhang SF; Liao DY; Xu H; Zhang WY; Li WM; Liu LX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):822-6. PubMed ID: 21302450
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer.
Zhou C; Che G; Zheng X; Qiu J; Xie Z; Cong Y; Pei X; Zhang H; Sun H; Ma H
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2663-2674. PubMed ID: 31541338
[TBL] [Abstract][Full Text] [Related]
9. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
Ma H; Wang L; Zhang T; Shen H; Du J
Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
[TBL] [Abstract][Full Text] [Related]
10. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
[TBL] [Abstract][Full Text] [Related]
12. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
[TBL] [Abstract][Full Text] [Related]
13. Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma.
Abdul-Ghafar J; Oh SS; Park SM; Wairagu P; Lee SN; Jeong Y; Eom M; Yong SJ; Jung SH
Tohoku J Exp Med; 2013 Feb; 229(2):153-62. PubMed ID: 23358237
[TBL] [Abstract][Full Text] [Related]
14. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
15. Expression of autophagy-related factor p62 for lung cancer diagnosis and prognosis: A systematic review and meta-analysis.
Wang BJ; Tang YD; Yu BY; Gui D; Xu H
Math Biosci Eng; 2019 Jul; 16(6):6805-6821. PubMed ID: 31698589
[TBL] [Abstract][Full Text] [Related]
16. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc.
Li HS; Lv RQ; Liu L
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Influence of Autophagy-Associated Proteins on Human Lung Cancer.
Chen Y; Schnitzler KL; Ma Y; Nenkov M; Theis B; Petersen I
Dis Markers; 2018; 2018():8314963. PubMed ID: 29545906
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
19. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection.
Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ
Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
